Abbott LaboratoriesMEX:ABT +1.26%81 FCF Margin % is 8.20% as of Mar. 2026, which is 49% below its 10-year median of 16.12. GuruFocus rates MEX:ABT with a GF Score™ of 81/100 and a GF Value™ of MXN2,267.11 (Modestly Undervalued). Among 815 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 85.89% on this metric.
The historical rank and industry rank for Abbott Laboratories's FCF Margin % or its related term are showing as below:
MEX:ABT'
s FCF Margin % Range Over the Past 10 Years
Min: 9.98 Med: 16.12 Max: 20.08
Current: 16.37
During the past 13 years, the highest FCF Margin % of Abbott Laboratories was 20.08%. The lowest was 9.98%. And the median was 16.12%.
MEX:ABT's FCF Margin % is ranked better than 85.89% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs MEX:ABT: 16.37
Abbott Laboratories FCF Margin % Related Terms
Abbott Laboratories FCF Margin % Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (MEX:ABT) has a FCF Margin % of 8.20% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Abbott Laboratories and its competitors. This is 49% below median its historical median of 16.12. Over the past decade, Abbott Laboratories' FCF Margin % has ranged from 9.98 to 20.08. According to the industry distribution chart, Abbott Laboratories ranks #115 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 14.1%.
Is Abbott Laboratories' FCF Margin % too high?
Abbott Laboratories' current FCF Margin % of 8.20% is 49% below median its 10-year median of 16.12. Over the past 10 years, this metric has ranged from a low of 9.98 to a high of 20.08. Based on the distribution chart, Abbott Laboratories ranks #115 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' FCF Margin % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #115 out of 815 companies for FCF Margin %. This places Abbott Laboratories in the top 14% of its industry — outperforming the majority of peers. Historically, Abbott Laboratories' own FCF Margin % has ranged from 9.98 to 20.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current FCF Margin % is 8.20%, which is 49% below median its own 10-year median of 16.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (MEX:ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN2,267.11, compared to a current price of MXN1,605.00 — trading 29.2% below its estimated fair value. The current FCF Margin % is 8.20%, which is 49% below median its 10-year median of 16.12. Abbott Laboratories' overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Abbott Laboratories (MEX:ABT), the current FCF Margin % is 8.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (MEX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of MXN1,605.00 is trading 29.2% below its estimated GF Value™ of MXN2,267.11.
GuruFocus considers Abbott Laboratories to be Modestly Undervalued.
Key valuation signals for MEX:ABT:
FCF Margin %: 8.20% (49% below median its 10-year median of 16.12)
GF Value™: MXN2,267.11 vs. price of MXN1,605.00 (29.2% below fair value)
No single metric tells the full story. See the MEX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
81GF Score
Get the complete analysis for MEX:ABT
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABT has been successfully added to your 
